HighTower Advisors’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$426K Sell
117,100
-9,000
-7% -$32.8K ﹤0.01% 2654
2025
Q1
$242K Buy
126,100
+32,750
+35% +$62.9K ﹤0.01% 3017
2024
Q4
$177K Hold
93,350
﹤0.01% 3204
2024
Q3
$122K Buy
93,350
+5,000
+6% +$6.54K ﹤0.01% 3243
2024
Q2
$89K Buy
88,350
+15,000
+20% +$15.1K ﹤0.01% 3189
2024
Q1
$135K Sell
73,350
-23,000
-24% -$42.3K ﹤0.01% 3056
2023
Q4
$119K Buy
96,350
+1,000
+1% +$1.24K ﹤0.01% 3123
2023
Q3
$109K Buy
95,350
+25,000
+36% +$28.6K ﹤0.01% 3059
2023
Q2
$65K Hold
70,350
﹤0.01% 3100
2023
Q1
$40K Buy
70,350
+10,925
+18% +$6.21K ﹤0.01% 3013
2022
Q4
$34K Buy
59,425
+7,401
+14% +$4.23K ﹤0.01% 3013
2022
Q3
$16K Buy
52,024
+6,300
+14% +$1.94K ﹤0.01% 2908
2022
Q2
$16K Sell
45,724
-2,958
-6% -$1.04K ﹤0.01% 2937
2022
Q1
$35K Sell
48,682
-11
-0% -$8 ﹤0.01% 3038
2021
Q4
$110K Hold
48,693
﹤0.01% 2870
2021
Q3
$141K Sell
48,693
-450
-0.9% -$1.3K ﹤0.01% 2778
2021
Q2
$187K Hold
49,143
﹤0.01% 2675
2021
Q1
$167K Sell
49,143
-342
-0.7% -$1.16K ﹤0.01% 2638
2020
Q4
$139K Sell
49,485
-2,552
-5% -$7.17K ﹤0.01% 2244
2020
Q3
$129K Buy
52,037
+15,781
+44% +$39.1K ﹤0.01% 2159
2020
Q2
$493K Buy
36,256
+450
+1% +$6.12K ﹤0.01% 1460
2020
Q1
$271K Hold
35,806
﹤0.01% 1608
2019
Q4
$226K Buy
35,806
+18,875
+111% +$119K ﹤0.01% 1882
2019
Q3
$66K Buy
16,931
+754
+5% +$2.94K ﹤0.01% 2182
2019
Q2
$79K Buy
+16,177
New +$79K ﹤0.01% 2161